Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1187431-43-1
Purity
95%
Trametinib is a kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer.
Properties
Name
Trametinib dimethyl sulfoxide
Smiles
CC(=O)NC=1C=CC=C(C1)N2C(=O)N(C3CC3)C(=O)C4=C(NC=5C=CC(I)=CC5F)N(C)C(=O)C(C)=C24.CS(=O)C
Targets
Please log in to see this information
SDS
GSK1120212 | JTP-74057 dimethylsulfoxide solvate | mekinist | trametinib | trametinib dimethyl sulfoxide
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$53
2 mg
$54
5 mg
$55
10 mg
$66
15 mg
$73
20 mg
$81
25 mg
$90
30 mg
$100
35 mg
$108
40 mg
$116
45 mg
$122
50 mg
$136
75 mg
$208
100 mg
$238
Quantity
1
Total amount
$ 55
GSK1120212 | JTP-74057 dimethylsulfoxide solvate | mekinist | trametinib | trametinib dimethyl sulfoxide
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:871700-17-3
0